Debra Kelsh
Psychiatry · Kansas City, KSNPI 1083716781
Payments from drug & device makers
What this record shows
That places this record below the midpoint for psychiatry clinicians in KS, where the typical reported total is $192.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$25,208,351in research payments, 2019–2025
Across 191 payments — averaging $131,981 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Azurity Pharmaceuticals, Inc.$7.5M
- Janssen Research & Development, LLC$7.4M
- Sage Therapeutics, LLC$4M
- Immedica Pharma US, Inc.$3.7M
- Cidara Therapeutics, Inc.$1.1M
- Astrazeneca UK Limited$670K
- plus $756K from 3 others
How this compares
$0 in reported general payments places this provider in the 10th percentile of 259 psychiatry providers in Kansas.
Other psychiatry in Kansas City
- Christine GlennKansas City$58K
- Dennis OwensKansas City$11K
- Gregory PrierKansas City$3K
- Ann GenoveseKansas City$3K
- Jennifer HansonKansas City$3K
- Navneet HundalKansas City$2K
- David WichmanManhattan$613K
- Kevin MaysLeawood$548K
- Sheldon PreskornWichita$498K
- James OwensSalina$433K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.